New Osteoporosis Drug Could Help Prevent Fractures.

                A large clinical trial of new osteoporosis drug found that it stimulates bone growth and prevents fractures at least as well as the only other such drug on market. The new drug, expected to win approval from federal regulators, would offer another much-needed treatment for people who have a disease that weakens bones and often leads to years of pain, disability and early death. Experts agree that new drug is urgently needed for this debilitation disease. People with osteoporosis have bones that are fragile and break easily. Bone is naturally lost with age. But osteoporosis is an extreme, abnormal bone loss that can cause devastating fractures, particularly of the spine and hip.The new drug looks promising, according to the clinical trial conducted by Radius. The trial compared the new drug, abaloparatide, with a placebo and with the only other bone building drug on the market. The new drug is a derivative of hormone that stimulate bone growth and it fill holes in osteoporotic bone appeared to fill faster.